To the full analysis
LIMES Schlosskliniken stock: growth
LIK.DELIMES Schlosskliniken reported $55.4M in revenue for fiscal 2025, up 33.5% on the prior year, up 35.3% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
29%
per year from 2017 to 2025, per share 27.8%
Earnings (Annual rate)
no data
Free cash flow (Annual rate)
6.1%
per year from 2017 to 2025, per share 5.2%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2017 | |
|---|---|---|
| Revenue | 35.3% | 29.0% |
| Revenue per share | 34.9% | 27.8% |
| Earnings | no data | no data |
| Earnings per share | no data | no data |
| Free cash flow | no data | 6.1% |
| Free cash flow per share | no data | 5.2% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2017 | $7.24M | −$1.39M | $509.48K |
| 2018 | $8.38M | −$1.62M | $1.77M |
| 2019 | $9.07M | −$914.22K | $1.78M |
| 2020 | $12.21M | −$769.48K | −$1.11M |
| 2021 | $25.97M | $4.37M | −$2.02M |
| 2022 | $31.92M | $4.66M | $7.04M |
| 2023 | $41.19M | $3.76M | −$3.89M |
| 2024 | $41.5M | $3.45M | $2.75M |
| 2025 | $55.4M | $6.31M | $820.26K |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = €0.9024)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Strong since 10 Nov 2026, previously Neutral
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.